Phathom Pharmaceuticals announced positive results from the phase 3 PHALCON-EE trial evaluating vonoprazan versus lansoprazole (Prevacid) for the treatment of erosive esophagitis. The trial successfully met its primary…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.